Oup Management Co., LLC Centessa Pharmaceuticals PLC Transaction History
Oup Management Co., LLC
- $44.5 Million
- Q3 2023
A detailed history of Oup Management Co., LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Oup Management Co., LLC holds 2,937,615 shares of CNTA stock, worth $42 Million. This represents 42.75% of its overall portfolio holdings.
Number of Shares
2,937,615
Previous 2,937,615
-0.0%
Holding current value
$42 Million
Previous $18.2 Million
4.53%
% of portfolio
42.75%
Previous 31.01%
Shares
2 transactions
Others Institutions Holding CNTA
# of Institutions
83Shares Held
96.6MCall Options Held
12.1KPut Options Held
3K-
Medicxi Ventures Management (Jersey) LTD20MShares$285 Million64.35% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$142 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$138 Million2.77% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.71MShares$81.7 Million1.82% of portfolio
-
First Light Asset Management, LLC Edina, MN4.78MShares$68.4 Million3.93% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.35B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...